Skip to main content
Caplight Logo









EsoCap AG

EsoCap AG

Private
BaselHealthcare & Life Scienceshttps://esocapbiotech.ch/

Last Round

Private Placement

Nov 18, 2021

Company Overview

EsoCap AG is a clinical-stage biotechnology company developing a drug delivery platform for the targeted topical treatment of esophageal diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

drug deliveryesophageal drug deliveryesophageal diseasedrug delivery techbiotechnologytargeted therapymucoadhesive filmeosinophilic esophagitisdrug-device combinationclinical-stage biotechpharma licensingmedical devicedrug delivery platformbiotech partneringgastroenterology biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

EsoCap AG Comparables

Compare EsoCap AG with similar companies based on industry and business-model similarity.

EsoCap AG comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Ellodi Pharmaceuticals
70%
Takeda
67%
Eupraxia Pharmaceuticals Inc.
66%

EsoCap AG Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Private PlacementNov 18, 2021
Private PlacementApr 30, 2019

EsoCap AG Investors

Notable investors and investment history

EsoCap AG investors
InvestorRounds
Canton of Basel-StadtPrivate Placement
Sandstorm VCPrivate Placement
CARELA HOLDINGVC Round, Private Placement

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 18, 2021

    Funded by CARELA HOLDING, Canton of Basel-Stadt, and Sandstorm VC.

EsoCap AG Filings

Explore SEC and related filing metadata, where available.

EsoCap AG filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about EsoCap AG's valuation, stock price, and market status.

Is EsoCap AG a public or private company?

EsoCap AG is a private company.

What is the current stock price of EsoCap AG?

EsoCap AG is a private company with no public stock price. Caplight tracks EsoCap AG's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is EsoCap AG worth (valuation)?

Valuation information for EsoCap AG is not publicly available.

Can I buy EsoCap AG stock?

EsoCap AG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was EsoCap AG's last funding round?

EsoCap AG's most recent funding round was Private Placement on November 18, 2021.

Who are the main investors in EsoCap AG?

Key investors in EsoCap AG include Canton of Basel-Stadt, Sandstorm VC, CARELA HOLDING.

Will EsoCap AG IPO soon?

No public IPO plans have been announced for EsoCap AG.

How can I track EsoCap AG secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor EsoCap AG's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBasel
Year Founded2017
Last FundingNov 18, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?